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Type I collagen is the most abundant structural protein in the body, playing 
a major role in the strength and integrity of connective tissues. Alterations 
in the synthesis and structure of type I collagen result in a number of 
connective tissue disorders, such as osteogenesis imperfecta and Ehlers-
Danlos syndrome. Type I collagen is normally a heterotrimeric type I collagen 
molecule composed of three pro β1(I) collagen chains and one proβ2(I) collagen 
chain. The COL1A2 deficient mouse produces only homotrimeric molecules, 
composed of three proβ1(I) collagen chains resulting from a functional null 
mutation in the COL1A2 gene. Recently our lab discovered a novel type I 
collagen glomerulopathy in the COL1A2 mouse. The novel glomerulopathy 
demonstrated increased collagen deposition in the renal glomerular mesangium. 
The collagen accumulation is similar to what is observed in the secondary 
progression of renal damage, caused by a variety of kidney disorders. This 
project entails the measurement of COL1A2 and COL1A1 mRNA levels discerning 
whether increased collagen deposition in the glomeruli mesangium in COL1A2 
deficient mice is related to increased type I collagen mRNA expression 
(pretranslational mechanism). These studies required harvesting kidneys from 
the COL1A2 deficient, heterozygous, and wildtype mice at one week, two weeks, 
and one month of age. Total RNA was isolated from harvested kidneys using the 
Qiagen RNAeasy RNA isolation kit, post mortar and pestle homogenization. The 
isolated total RNA was then analyzed for amount and quality via 
spectrophotometer at 260nm and 280nm, and 80ng of total RNA was used for cDNA 
generation via reverse transcriptase polymerase chain reaction using Promega 
ImpromII reagents. PCR products were generated for mouse COL1A2 transcripts 
using primers optimized for Real Time PCR analysis (RT-PCR). Quantitation of 
the COL1A1 and COL1A2 transcripts was obtained on the Roche LightCycler, with 
SYBR green monitoring after each amplification cycle. Previous in situ 
hybridization data suggests that there may not be an increase in mRNA. The 
study will attempt to gain a greater understanding of the molecular mechanism 
leading to type I collagen accumulation in the renal mesangium, with future 
application to understanding the role of extracellular matrix deposition in 
renal pathology and disease. 
 
